IP Alert: The Safe Harbor for Divisional Applications Shrinks
NEWS -The Safe Harbor for Divisional Applications Shrinks By Sarah A. Kagan The U.S. Court of Appeals for the Federal Circuit affirmed on January 23, 2018, the U.S. Patent and
The Safe Harbor for Divisional Applications Shrinks By Sarah A. Kagan The U.S. Court of Appeals for the Federal Circuit affirmed on January 23, 2018, the U.S. Patent and
Heather R. Smith-Carra examines several noteworthy updates and decisions to the Digital Millennium Copyright Act in the IPWatchdog article, “DMCA 2017: 9th Cir. decides safe harbor, anti-circumvention cases.” Click here to read the article.
Matthew P. Becker, Joseph J. Berghammer, Aaron Bowling, Scott A. Burow, Marc S. Cooperman, Azuka C. Dike, Audra C. Eidem Heinze, Katie Laatsch Fink, Sean J. Jungels, Kevin C. Keenan,
Heather R. Smith-Carra examines why video game companies are seeking Digital Millennium Copyright Act exemptions for online video game preservation in IPWatchdog. Ms. Smith-Carra co-wrote the article with IPWatchdog editor Gene Quinn.
Matthew P. Becker examines the U.S. Court of Appeals for the Federal Circuit’s recent decision in Exmark Manufacturing Company v. Briggs & Stratton Power, and how it signals a continued shift in
Banner & Witcoff is pleased to note that it has joined with other IP lawyers in representing the American Bar Association as amicus curiae in a case in the U.S.
Banner & Witcoff is recognized as a top firm in the 2018 edition of the World Trademark Review 1000, a standalone publication that recommends leading individual practitioners and their firms in the trademark
Step One and Done to Patent Eligibility: Finjan, Inc. v. Blue Coat Systems, Inc. By Aseet Patel and Peter Nigrelli The U.S. Court of Appeals for the Federal Circuit
Can a Potential Infringer Use an IPR to Gain Access to Article III Courts? By Sarah A. Kagan The U.S. Court of Appeals for the Federal Circuit heard arguments
Did the Supreme Court Bless Claims to Methods of Treating? By Sarah A. Kagan At the U.S. Court of Appeals for the Federal Circuit oral argument in Vanda Pharmaceuticals